Aquestive Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -0.14%
- Market cap
- $448.71M
- 125.69M shares
- Filings
- 692
Q3 2026−22.6% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+69.4% FY25 yoy
- $448.71M
- —
- 9.2×
- —
- -9.07%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $44,545,000 | reported | |
| FY 2024 | 2024-12-31 | $57,561,000 | reported | |
| FY 2023 | 2023-12-31 | $50,583,000 | reported | |
| FY 2022 | 2022-12-31 | $47,680,000 | reported | |
| FY 2021 | 2021-12-31 | $50,832,000 | reported | |
| FY 2020 | 2020-12-31 | $45,849,000 | reported | |
| FY 2019 | 2019-12-31 | $52,609,000 | reported | |
| FY 2018 | 2018-12-31 | $67,430,000 | reported | |
| FY 2017 | 2017-12-31 | $66,918,000 | reported |
Segments
LineFY2025ShareChange
United States$29.60M66%−25.9%
Ex-United States$14.94M34%−15.3%
Total$44.55M
Pharmaceutical preparations
Aquestive Therapeutics, Inc. is the 132nd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
GOSSGossamer Bio, Inc.$48.5M57.7%351.5%$68.0MPTGXProtagonist Therapeutics, Inc$46.0M89.4%282.8%$8.8BSEPNSepterna, Inc.$46.0M4,174.5%106.4%$2.0B
AQSTAquestive Therapeutics, Inc. (this company)$44.5M22.6%188.1%$448.7M
CPIXCumberland Pharmaceuticals Inc$44.5M17.6%6.4%$98.5MINBPIntegrated Biopharma Inc$43.9M19.3%6.5%$9.1MXLOXilio Therapeutics, Inc.$43.8M589.9%80.1%$58.3MWVEWave Life Sciences, Inc.$42.7M60.5%478.3%$622.3MBFRIBiofrontera Inc.$41.7M11.7%25.3%$16.9MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Aquestive Therapeutics, Inc. · CIK 1398733 · Engraved from SEC EDGAR